Kryscio R - Search Results

1

Glial cell line-derived neurotrophic factor-levodopa interactions and reduction of side effects in parkinsonian monkeys.

Miyoshi Y, Zhang Z, Ovadia A, Lapchak PA, Collins F, Hilt D, Lebel C, Kryscio R, Gash DM. Miyoshi Y, et al. Among authors: kryscio r. Ann Neurol. 1997 Aug;42(2):208-14. doi: 10.1002/ana.410420212. Ann Neurol. 1997. PMID: 9266731

2

Monoaminergic and cholinergic synaptic markers in the nucleus basalis of Meynert (nbM): normal age-related changes and the effect of heart disease and Alzheimer's disease.

Sparks DL, Hunsaker JC 3rd, Slevin JT, DeKosky ST, Kryscio RJ, Markesbery WR. Sparks DL, et al. Among authors: kryscio rj. Ann Neurol. 1992 Jun;31(6):611-20. doi: 10.1002/ana.410310608. Ann Neurol. 1992. PMID: 1355334

3

GDNF protection against 6-OHDA: time dependence and requirement for protein synthesis.

Kearns CM, Cass WA, Smoot K, Kryscio R, Gash DM. Kearns CM, et al. Among authors: kryscio r. J Neurosci. 1997 Sep 15;17(18):7111-8. doi: 10.1523/JNEUROSCI.17-18-07111.1997. J Neurosci. 1997. PMID: 9278545 Free PMC article.

4

Dose response to intraventricular glial cell line-derived neurotrophic factor administration in parkinsonian monkeys.

Zhang Z, Miyoshi Y, Lapchak PA, Collins F, Hilt D, Lebel C, Kryscio R, Gash DM. Zhang Z, et al. Among authors: kryscio r. J Pharmacol Exp Ther. 1997 Sep;282(3):1396-401. J Pharmacol Exp Ther. 1997. PMID: 9316852

5

Critical decline in fine motor hand movements in human aging.

Smith CD, Umberger GH, Manning EL, Slevin JT, Wekstein DR, Schmitt FA, Markesbery WR, Zhang Z, Gerhardt GA, Kryscio RJ, Gash DM. Smith CD, et al. Among authors: kryscio rj. Neurology. 1999 Oct 22;53(7):1458-61. doi: 10.1212/wnl.53.7.1458. Neurology. 1999. PMID: 10534251

6

Memories that last in old age: motor skill learning and memory preservation.

Smith CD, Walton A, Loveland AD, Umberger GH, Kryscio RJ, Gash DM. Smith CD, et al. Among authors: kryscio rj. Neurobiol Aging. 2005 Jun;26(6):883-90. doi: 10.1016/j.neurobiolaging.2004.08.014. Neurobiol Aging. 2005. PMID: 15718047 Clinical Trial.

7

Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line-derived neurotrophic factor.

Slevin JT, Gerhardt GA, Smith CD, Gash DM, Kryscio R, Young B. Slevin JT, et al. Among authors: kryscio r. J Neurosurg. 2005 Feb;102(2):216-22. doi: 10.3171/jns.2005.102.2.0216. J Neurosurg. 2005. PMID: 15739547

8

Research on Parkinson disease.

Slevin JT, Gerhardt GA, Smith CD, Gash DM, Kryscio R, Young B. Slevin JT, et al. Among authors: kryscio r. J Neurosurg. 2005 Feb;102(2):401. J Neurosurg. 2005. PMID: 15739575 Clinical Trial. No abstract available.

9

Unilateral intraputaminal glial cell line-derived neurotrophic factor in patients with Parkinson disease: response to 1 year each of treatment and withdrawal.

Slevin JT, Gash DM, Smith CD, Gerhardt GA, Kryscio R, Chebrolu H, Walton A, Wagner R, Young AB. Slevin JT, et al. Among authors: kryscio r. Neurosurg Focus. 2006 May 15;20(5):E1. doi: 10.3171/foc.2006.20.5.2. Neurosurg Focus. 2006. PMID: 16711657

10

Unilateral intraputamenal glial cell line-derived neurotrophic factor in patients with Parkinson disease: response to 1 year of treatment and 1 year of withdrawal.

Slevin JT, Gash DM, Smith CD, Gerhardt GA, Kryscio R, Chebrolu H, Walton A, Wagner R, Young AB. Slevin JT, et al. Among authors: kryscio r. J Neurosurg. 2007 Apr;106(4):614-20. doi: 10.3171/jns.2007.106.4.614. J Neurosurg. 2007. PMID: 17432712 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

349 results

Search Page

Filters